2C-B-DragonFLY

A psychedelic phenethylamine of the 2C family

2C-B-DragonFLY is a psychedelic compound belonging to the 2C family of phenethylamines. It is a derivative of the more well-known psychedelic 2C-B, and is structurally related to the benzodifuran class of compounds. The compound is known for its potent psychedelic effects and long duration of action.

Chemical Structure and Properties

2C-B-DragonFLY is chemically classified as a phenethylamine, with a molecular structure that includes a bromine atom and two methoxy groups attached to a benzodifuran core. The IUPAC name for 2C-B-DragonFLY is 1-(8-bromo-2,3,6,7-tetrahydrobenzo[1,2-b:4,5-b']difuran-4-yl)-2-(2,5-dimethoxyphenyl)ethan-1-amine. This structure is similar to other compounds in the 2C family, but with the addition of the benzodifuran moiety, which is responsible for its unique properties.

Pharmacology

2C-B-DragonFLY acts primarily as a serotonin receptor agonist, with a high affinity for the 5-HT2A receptor, which is believed to be responsible for its psychedelic effects. The compound also interacts with other serotonin receptors, including 5-HT2B and 5-HT2C, contributing to its complex pharmacological profile.

Effects

The effects of 2C-B-DragonFLY are similar to those of other psychedelics, such as LSD and psilocybin, but with some distinct differences. Users report visual hallucinations, altered perception of time and space, and profound changes in thought and mood. The effects can last significantly longer than those of 2C-B, often extending up to 12-24 hours, depending on the dose and individual metabolism.

Safety and Toxicity

Due to its potency and long duration, 2C-B-DragonFLY poses significant risks, especially in unregulated settings. There have been reports of severe adverse reactions, including vasoconstriction, which can lead to dangerous cardiovascular effects. As with many research chemicals, the long-term safety profile of 2C-B-DragonFLY is not well understood, and caution is advised.

Legal Status

2C-B-DragonFLY is not specifically controlled under international drug treaties, but its legal status varies by country. In some jurisdictions, it may be considered an analogue of controlled substances, making it illegal under analogue laws.

History and Research

2C-B-DragonFLY was first synthesized in the early 2000s as part of research into new psychedelic compounds. It gained attention in the research chemical market due to its potent effects and novelty. However, due to safety concerns and legal issues, its use has remained limited primarily to research settings.

Also see

• 2C-B
• Phenethylamine
• Psychedelic drug
• Serotonin receptor
• Research chemical